Click for best price
T Cell Transfer Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for T Cell Transfer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T Cell Transfer Therapy. This report contains market size and forecasts of T Cell Transfer Therapy in global, including the following market information:
Global T Cell Transfer Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global T Cell Transfer Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Autologous Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of T Cell Transfer Therapy include Roche, Merck, Novartis, Johnson & Johnson, Glaxosmithkline, Amgen, Abbvie, Astrazeneca and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the T Cell Transfer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T Cell Transfer Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global T Cell Transfer Therapy Market Segment Percentages, by Type, 2022 (%)
Autologous
Allogeneic
Global T Cell Transfer Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global T Cell Transfer Therapy Market Segment Percentages, by Application, 2022 (%)
Child
Adult
The Elderly
Global T Cell Transfer Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global T Cell Transfer Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies T Cell Transfer Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies T Cell Transfer Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of T Cell Transfer Therapy, market overview.
Chapter 2: Global T Cell Transfer Therapy market size in revenue.
Chapter 3: Detailed analysis of T Cell Transfer Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of T Cell Transfer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
T Cell Transfer Therapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 T Cell Transfer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T Cell Transfer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T Cell Transfer Therapy Overall Market Size
2.1 Global T Cell Transfer Therapy Market Size: 2022 VS 2032
2.2 Global T Cell Transfer Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top T Cell Transfer Therapy Players in Global Market
3.2 Top Global T Cell Transfer Therapy Companies Ranked by Revenue
3.3 Global T Cell Transfer Therapy Revenue by Companies
3.4 Top 3 and Top 5 T Cell Transfer Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies T Cell Transfer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T Cell Transfer Therapy Players in Global Market
3.6.1 List of Global Tier 1 T Cell Transfer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 T Cell Transfer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global T Cell Transfer Therapy Market Size Markets, 2022 & 2032
4.1.2 Autologous
4.1.3 Allogeneic
4.2 By Type - Global T Cell Transfer Therapy Revenue & Forecasts
4.2.1 By Type - Global T Cell Transfer Therapy Revenue, 2018-2023
4.2.2 By Type - Global T Cell Transfer Therapy Revenue, 2024-2032
4.2.3 By Type - Global T Cell Transfer Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T Cell Transfer Therapy Market Size, 2022 & 2032
5.1.2 Child
5.1.3 Adult
5.1.4 The Elderly
5.2 By Application - Global T Cell Transfer Therapy Revenue & Forecasts
5.2.1 By Application - Global T Cell Transfer Therapy Revenue, 2018-2023
5.2.2 By Application - Global T Cell Transfer Therapy Revenue, 2024-2032
5.2.3 By Application - Global T Cell Transfer Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global T Cell Transfer Therapy Market Size, 2022 & 2032
6.2 By Region - Global T Cell Transfer Therapy Revenue & Forecasts
6.2.1 By Region - Global T Cell Transfer Therapy Revenue, 2018-2023
6.2.2 By Region - Global T Cell Transfer Therapy Revenue, 2024-2032
6.2.3 By Region - Global T Cell Transfer Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America T Cell Transfer Therapy Revenue, 2018-2032
6.3.2 US T Cell Transfer Therapy Market Size, 2018-2032
6.3.3 Canada T Cell Transfer Therapy Market Size, 2018-2032
6.3.4 Mexico T Cell Transfer Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe T Cell Transfer Therapy Revenue, 2018-2032
6.4.2 Germany T Cell Transfer Therapy Market Size, 2018-2032
6.4.3 France T Cell Transfer Therapy Market Size, 2018-2032
6.4.4 U.K. T Cell Transfer Therapy Market Size, 2018-2032
6.4.5 Italy T Cell Transfer Therapy Market Size, 2018-2032
6.4.6 Russia T Cell Transfer Therapy Market Size, 2018-2032
6.4.7 Nordic Countries T Cell Transfer Therapy Market Size, 2018-2032
6.4.8 Benelux T Cell Transfer Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia T Cell Transfer Therapy Revenue, 2018-2032
6.5.2 China T Cell Transfer Therapy Market Size, 2018-2032
6.5.3 Japan T Cell Transfer Therapy Market Size, 2018-2032
6.5.4 South Korea T Cell Transfer Therapy Market Size, 2018-2032
6.5.5 Southeast Asia T Cell Transfer Therapy Market Size, 2018-2032
6.5.6 India T Cell Transfer Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America T Cell Transfer Therapy Revenue, 2018-2032
6.6.2 Brazil T Cell Transfer Therapy Market Size, 2018-2032
6.6.3 Argentina T Cell Transfer Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa T Cell Transfer Therapy Revenue, 2018-2032
6.7.2 Turkey T Cell Transfer Therapy Market Size, 2018-2032
6.7.3 Israel T Cell Transfer Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia T Cell Transfer Therapy Market Size, 2018-2032
6.7.5 UAE T Cell Transfer Therapy Market Size, 2018-2032
7 T Cell Transfer Therapy Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche T Cell Transfer Therapy Major Product Offerings
7.1.4 Roche T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck T Cell Transfer Therapy Major Product Offerings
7.2.4 Merck T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis T Cell Transfer Therapy Major Product Offerings
7.3.4 Novartis T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson T Cell Transfer Therapy Major Product Offerings
7.4.4 Johnson & Johnson T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Company Summary
7.5.2 Glaxosmithkline Business Overview
7.5.3 Glaxosmithkline T Cell Transfer Therapy Major Product Offerings
7.5.4 Glaxosmithkline T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.5.5 Glaxosmithkline Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen T Cell Transfer Therapy Major Product Offerings
7.6.4 Amgen T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Abbvie
7.7.1 Abbvie Company Summary
7.7.2 Abbvie Business Overview
7.7.3 Abbvie T Cell Transfer Therapy Major Product Offerings
7.7.4 Abbvie T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.7.5 Abbvie Key News & Latest Developments
7.8 Astrazeneca
7.8.1 Astrazeneca Company Summary
7.8.2 Astrazeneca Business Overview
7.8.3 Astrazeneca T Cell Transfer Therapy Major Product Offerings
7.8.4 Astrazeneca T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.8.5 Astrazeneca Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb T Cell Transfer Therapy Major Product Offerings
7.9.4 Bristol-Myers Squibb T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 ELI Lilly
7.10.1 ELI Lilly Company Summary
7.10.2 ELI Lilly Business Overview
7.10.3 ELI Lilly T Cell Transfer Therapy Major Product Offerings
7.10.4 ELI Lilly T Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.10.5 ELI Lilly Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. T Cell Transfer Therapy Market Opportunities & Trends in Global Market
Table 2. T Cell Transfer Therapy Market Drivers in Global Market
Table 3. T Cell Transfer Therapy Market Restraints in Global Market
Table 4. Key Players of T Cell Transfer Therapy in Global Market
Table 5. Top T Cell Transfer Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global T Cell Transfer Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global T Cell Transfer Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies T Cell Transfer Therapy Product Type
Table 9. List of Global Tier 1 T Cell Transfer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T Cell Transfer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global T Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - T Cell Transfer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - T Cell Transfer Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global T Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - T Cell Transfer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - T Cell Transfer Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global T Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global T Cell Transfer Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global T Cell Transfer Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America T Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe T Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia T Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America T Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa T Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Roche Company Summary
Table 31. Roche T Cell Transfer Therapy Product Offerings
Table 32. Roche T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck T Cell Transfer Therapy Product Offerings
Table 36. Merck T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis T Cell Transfer Therapy Product Offerings
Table 40. Novartis T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson T Cell Transfer Therapy Product Offerings
Table 44. Johnson & Johnson T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Glaxosmithkline Company Summary
Table 47. Glaxosmithkline T Cell Transfer Therapy Product Offerings
Table 48. Glaxosmithkline T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Glaxosmithkline Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen T Cell Transfer Therapy Product Offerings
Table 52. Amgen T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Abbvie Company Summary
Table 55. Abbvie T Cell Transfer Therapy Product Offerings
Table 56. Abbvie T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Abbvie Key News & Latest Developments
Table 58. Astrazeneca Company Summary
Table 59. Astrazeneca T Cell Transfer Therapy Product Offerings
Table 60. Astrazeneca T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Astrazeneca Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb T Cell Transfer Therapy Product Offerings
Table 64. Bristol-Myers Squibb T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. ELI Lilly Company Summary
Table 67. ELI Lilly T Cell Transfer Therapy Product Offerings
Table 68. ELI Lilly T Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. ELI Lilly Key News & Latest Developments
List of Figures
Figure 1. T Cell Transfer Therapy Segment by Type in 2022
Figure 2. T Cell Transfer Therapy Segment by Application in 2022
Figure 3. Global T Cell Transfer Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global T Cell Transfer Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global T Cell Transfer Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by T Cell Transfer Therapy Revenue in 2022
Figure 8. By Type - Global T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global T Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global T Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 16. US T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 20. Germany T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 28. China T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa T Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE T Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Roche T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Glaxosmithkline T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Abbvie T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Astrazeneca T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. ELI Lilly T Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
